This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Elsevier Launches PracticeUpdate, A Free Information Portal For Physicians

PHILADELPHIA, March 20, 2013 /PRNewswire/ --

PracticeUpdate tailors information to physician specialties, providing news and journal content selected by expert editors

Elsevier, the leading provider of scientific, technical and medical information products and services, today announced the launch of PracticeUpdate, a free website featuring high-quality, relevant medical information and education resources. The site is aimed at the millions of physicians who seek news and articles to help them diagnose and treat their patients. PracticeUpdate ( http://www.practiceupdate.com) is free to registered users and supported by advertisers.

PracticeUpdate cuts through volumes of information for its users, who register and create profiles, which enable PracticeUpdate's editorial board to hand-select the peer-reviewed journal content that will help physicians of any specialty generate better outcomes for their patients. PracticeUpdate helps clinicians, who do not have time to run through hundreds of articles published every day, stay current with their industry and their specialties. PracticeUpdate will launch with oncology, cardiology, dermatology, eye care (ophthalmology and optometry), primary care, and urology, with more to be added later this year.

"In addition to selecting the best and most relevant content, our PracticeUpdate experts add their context and perspectives, thereby allowing our readers to discover what really matters for patient care," said Allison Risko, Vice President for Specialty Products, Elsevier. "Our experts hand-select the findings that matter from hundreds of journals and other news sources."

The expert editors-in-chief of PracticeUpdate include Lee S. Schwartzberg MD, FACP (Oncology); Douglas P. Zipes, MD (Cardiology); Robert T. Brodell, MD (Dermatology); Paul B. Freeman, OD, FAAO, FCOVD, and Myron Yanoff, MD (Eye Care co-editors-in-chief); David Rakel, MD (Primary Care); Alan J. Wein, MD, FACS, PhD (Hon) (Urology).

The forerunner for PracticeUpdate is Elsevier's OncologySTAT, which launched in 2007 and was Elsevier's - and the industry's - first free site aimed at oncologists and supported by advertising. Today the OncologySTAT community is composed of about 65,000 healthcare practitioners (other types of physicians, nurses, healthcare workers) in the US and around the world, including more than 8,000 self-identified U.S. oncologists and hematologists. OncologySTAT's registered users will be able to transition to the oncology portal of the new PracticeUpdate to access the same content they have come to expect.

PracticeUpdate and its editorial boards deliver:

  • Content geared to clinicians, updated daily
  • Weekly scans of premiere medical journals
  • News, research, and clinical findings hand-selected from the top research and clinical evidence
  • Expert summary and commentary to put the most important and relevant findings into perspective
  • Access from any mobile device, including laptops, smartphones, and tablets

In addition, PracticeUpdate will deliver the ability for users to fine-tune their content based on specialty and other interests and will include community features enabling validated physicians to share their practice experiences.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,912.11 -70.48 -0.42%
S&P 500 1,969.95 -8.96 -0.45%
NASDAQ 4,442.6980 -2.2110 -0.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs